Tablet containing hardly soluble active ingredient

Details for Australian Patent Application No. 2006260201 (hide)

Owner Takeda Pharmaceutical Company Limited

Inventors Marunaka, Shigeyuki; Fukuta, Makoto

Agent Griffith Hack

Pub. Number AU-B-2006260201

PCT Pub. Number WO2006/137443

Priority 2005-182415 22.06.05 JP

Filing date 21 June 2006

Wipo publication date 28 December 2006

Acceptance publication date 20 October 2011

International Classifications

A61K 31/407 (2006.01) - condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine

A61K 9/28 (2006.01) Medicinal preparations characterised by special physical form - Dragees

A61K 47/12 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carboxylic acids

A61K 47/38 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Cellulose

A61P 25/20 (2006.01) Drugs for disorders of the nervous system

Event Publications

10 January 2008 PCT application entered the National Phase

  PCT publication WO2006/137443 Priority application(s): WO2006/137443

20 October 2011 Application Accepted

  Published as AU-B-2006260201

16 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006260216-Fuel feeder of engine

2006260184-Prophylactic or therapeutic agent for corneal/conjunctival disease